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ABSTRACT 
Little research has been done on the most appropriate 
living and care environment for those living with 
Alzheimer’s disease. With current predictions showing 
that over 16 million people will be living with 
Alzheimer’s disease by the year 2050, it is important that 
practitioners become aware of how living environments 
may help or hinder the treatment of the disease. This 
study is an exploratory longitudinal study aimed at 
understanding how the disease progresses among 
different living environments. The study examines the 
difference in the mean stage of the disease over a 6 year 
period in 3 living environments, including individuals 
living at home independently, those living at home or 
with relatives but with assistance, and those living in an 
assisted living facility. 374 participants were asked to 
participate in the study by responding to a 122-question 
online survey. The study showed that the mean 
difference in the stage of the disease in early years shows 
to be lower in those who live at home independently, 
however, in later years the mean difference is lowest in 
those living in an assisted living facility. This could 
suggest that the progression of the disease is slower in 
familiar environments that involve routine tasks when 
cognition is mildly impaired. This could also suggest that 
the development of Alzheimer’s disease is slower in an 
assisted living facility when cognition is more 
significantly impaired. 
Keywords: Alzheimer’s disease, empirically test, 
environment  
INTRODUCTION 
The prevalence of Alzheimer’s disease in the world 
is growing and is anticipated to continue growing. 
Alzheimer’s disease causes those diagnosed with it 
to slowly become less able to care for them until 
independent living is no longer possible. This 
leaves family members with a difficult decision to 
make. Will the patient have a better life at home 
with family or in a long term care facility that has 
trained nursing staff available? 
For the over 5 million people living with 
Alzheimer’s disease this question has been a 
personal choice for each family with little 
information available to help them make this 
difficult decision. The goal of this study is to 
determine whether the speed of progression of 
Alzheimer’s disease can be associated with the 
environment in which the patient lives. There is 
little research that ties the progression of 
Alzheimer’s disease to where the patient lives and 
no apparent research that compares the progression 
in two or more different living environments. 
This exploratory study sought to create a basis for 
later, more detailed research. The study was an 
investigation of the progression of Alzheimer’s 
disease over the last 5 years in patients who have 
already been diagnosed as possible, probable, or 
confirmed Alzheimer’s disease. In order to study 
this progression as accurately as possible, the 
caregivers, close friends, or relatives of the patients 
were surveyed using an online survey. 
This survey included demographic information as 
well as questions about the cognitive abilities of the 
patient for the previous 5 years at 1 year intervals. 
The environment in which the patient lives 
(whether assisted living or in a private home) was 
compared with the cognitive abilities of the patient 
to find any correlation between living environment 
and the speed of progression of Alzheimer’s 
disease. 
Commonality of Alzheimer ’s disease 
Alzheimer’s disease is currently experienced by 
nearly 44 million people worldwide and by over 5 
million people in the world (Prince et al., 2014; 
U.S. Department of Health & Human Services, 
2016). This form of dementia is the most common 
form for geriatric patients (U.S. Department of 
Health & Human Services, 2016). Although a large 
number of people worldwide currently have 
Alzheimer’s disease, only about 25% of those with 
the disease have been diagnosed and are receiving 
treatment (Prince et al., 2014). Worldwide, 
Alzheimer’s disease is the leading cause of 
disability in geriatric patients (Prince et al., 2014). 
DSM-V Categorization 
While a patient is living he or she can only be 
diagnosed with “probable” or “possible” 
Alzheimer’s disease. This is because the disease 
cannot technically be diagnosed until the brain is 
ISSN: 2321-8819 (Online) 2348-7186 (Print) Impact Factor: 1.498 Vol. 6, Issue 3, March, 2018  
146 







autopsied. Alzheimer’s disease is categorized in the 
Diagnostic and Statistical Manual of Mental 
Disorders, fifth edition (DSM-5) as a 
neurocognitive disorder. Before being diagnosed, 
the patient must first meet the criteria for major or 
mild neurocognitive disorder. 
In order to diagnose a patient with Alzheimer’s 
disease there must also be a gradual progression of 
cognitive impairment in one or more domains. 
Alzheimer’s disease can be categorized as either a 
major or a mild neurocognitive disorder. For a 
probable major neurocognitive disorder diagnosis 
there must be evidence of a genetic mutation. There 
must also be a decline in memory and learning and 
at least one other cognitive domain. Evidence of a 
gradual decline in cognition is also required for 
diagnosis. 
Caregiving 
Many families choose to care for family members 
diagnosed with Alzheimer’s disease themselves, 
opting out of assisted living communities. Over 
40% of Alzheimer’s related family care givers 
report a high level of emotional stress that directly 
relates to their role as a caregiver (Prince et al., 
2014). Alzheimer’s and dementia caregivers seek 
medical care at a much higher rate than the rest of 
society, accruing an additional $9.7 billion in 
healthcare costs in 2014 alone (Alzheimer’s 
Association, 2015). 
Caregivers often report that they would feel guilty 
if they did not personally care for their loved one 
diagnosed with Alzheimer’s disease and felt that 
they did not have a choice in caring for the family 
member. Seventy-four percent of these caregivers 
reported that they were very concerned about their 
own health and that this concern has significantly 
increased since becoming a caregiver 
(NAC/AARP, 2009). Fifteen million people 
worked as unpaid caregivers for people with 
Alzheimer’s disease in 2014, accruing 17.9 billion 
hours of unpaid work (Alzheimer’s Association, 
2015). 
Caregivers can be family members or hired help 
who care for the individual at his or her home or 
they can be staff members at an assisted living 
facility or nursing home. Lee, Walker, and Shoup 
(2001) found that caregivers who work longer 
hours tend to experience depression at higher rates 
than those who work fewer hours. The authors also 
found that caregivers who were unpaid family 
members often suffered depression at a higher rate 
than those who were nonfamily paid workers. 
These feelings of depression often contribute to 
family members choosing to care for their loved 
ones longer than they are qualified to do so (Lee et 
al., 2001). Lee et al. (2001) suggested that hired 
help in the home can make the patient feel 
confusion and can cause family members who had 
previously been caring for the patient to feel 
inadequate. 
Treatment Options for Alzheimer’s Disease 
Cherrier et al. (2005) found that increased levels of 
testosterone, even if those levels were increased 
due to a supplement, helped to improve special and 
verbal memory functioning in men. The study did 
not include women, so the effect of testosterone on 
women was not studied. 
In a 2012 study Shaw et al. found that hormone 
therapy initiated later in life correlates with an 
increased rate of Alzheimer’s disease diagnosis. 
The authors observed the usage of hormone therapy 
in correlation with the probability of being 
diagnosed with Alzheimer’s disease. Women who 
began hormone placement therapy only after 
menopause showed higher levels of Alzheimer’s 
disease diagnosis later in life (Show et al., 2012). 
Azcurra (2012) found that Alzheimer’s patients 
who participated in reminiscence therapy showed a 
significant improvement in quality of life and 
engagement with those around them. Azcurra 
studied only participants who lived in long term 
care facilities. A total of 135 participants were 
recruited and were evaluated during a 6-month 
period. The study found that, although cognition 
was not improved by the treatment, behavior and 
quality of life were greatly improved. 
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Effects on Cognition 
Stoirandt (2008) found that changes in cognition 
are often most notable in aspects of personality 
even before memory difficulty is noticed. Over 
time, the disease will create an increasing decline 
in cognitive ability. This decline will affect both 
stored memories and the ability to make new 
memories (Storandt, 2008). According to Storandt 
(2008), episodic memory is often the first symptom 
that is noticed by families as an Alzheimer’s disuse 
concern. People who experience episodic memory 
decline often repeat stories or questions and may 
leave a task when they are only partially finished 
with it, forgetting to return to complete the task. 
Uc, Rizzo, Anderson, Shi, and Dawson (2004) 
found that visual search is often impaired in 
patients with Alzheimer’s disease. Visual search 
allows people to quickly scan a place or document 
for a specific object or work that they are looking 
for. Uc et al. found in their 2004 study that 
individuals diagnosed with Alzheimer’s disease 
reported seeing less during a visual search exercise 
than participants who were neurologically healthy. 
Backman et al. (2005) found that perceptual speed 
is diminished in patients with Alzheimer’s disease. 
Perceptual speed, which allows individuals to 
compare and contrast 
visually processed information nearly 
instantaneously, could prove dangerous when 
diminished. Diminished perceptual speed could 
lead to grave miscalculations for an individual 
living with Alzheimer’s disease. In a follow up 
study in 2008 Boyle, Wilson, Schneider, Bienias, 
and Bennett found that not all patients with 
Alzheimer’s disease experience reduced perceptual 
speed. The researchers found that those who do not 
experience this loss can often mask the symptoms 
of Alzheimer’s disease longer than those who do 
experience a loss in perceptual speed. 
Alzheimer’s disease nearly always affects 
executive functioning at some point during the 
course of the disease (Becker, 2004). Executive 
functioning is necessary for time management and 
organizational skills. Individuals who lost 
executive functioning ability may make major 
miscalculations in time and may forget that they 
have already asked a question or told a story. 
Alzheimer’s patients experiencing a loss of 
executive functioning may also forget where they 
have even when in familiar places with familiar 
people (Becker, 2004). Marshall, McGurk, Karow, 
and Kairy (2007) found that loss in executive 
functioning may also lead to difficulty solving 
simple problems or completing simple tasks. The 
authors explained that this is a result of the inability 
for individuals with Alzheimer’s disease to 
organize their thoughts. The study found that 
individuals with Alzheimer’s disease and other 
neurocognitive diseases or disorders became 
frustrated when given a problem to solve, such as a 
block design test. The participants in the study 
were noted to be inconsistent, disorganized, and 
impatient (Marshall et al., 2007). 
Macduffie, Atkins, Flegal, Clark, and Reuter-
Lorenz (2012) found that individuals with 
Alzheimer’s disease reported that they were often 
unsure of the truth and validity of their memories. 
This was true even after the individuals had been 
recently given new information to help trigger the 
memory. Memories that are preserved during 
Alzheimer’s disease are often distorted (Macduffie 
et al., 2012). 
In later stages of the disease, speech and language 
can be greatly diminished (Taler & Phillips, 2008). 
Issues with speech and language typically increase 
as other symptoms become more severe. During 
their 2001 study, Altman, Kempler, and Andersen 
asked participants both with and without 
Alzheimer’s disease to recite a sentence of their 
choosing using correct nouns and verbs. The study 
found that those with Alzheimer’s disease often 
mistakenly left out words or added unnecessary 
words to their sentences. Consequently, the 
individuals who did not have Alzheimer’s disease 
performed significantly better than those with the 
disease (Altman et al., 2001). 
METHODS 
This study uses a longitudinal survey design to 
assess the mean difference of the stages of 
Alzheimer’s disease over a six-year period in three 
different living environments. The purpose of the 
design of this study is to compare the living 
environment (whether the individual lived 
independently at home, at home but depended on 
others or in an assisted living environment) with 
the severity of symptoms at yearly intervals. 
Sampling 
Because the population being studied have 
cognitive impairments by nature, it would not 
likely be beneficial to ask individuals with 
Alzheimer’s disease questions about their own 
symptoms and cognitive deficiencies. Instead 
family members, physicians, and caretakers were 
surveyed. Through the use of an online survey 300 
people were targeted from a variety of geographical 
locations. Although a larger sample will yield a 
smaller margin of error, a larger study is not 
possible at this time. 
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A purposive sampling was used for this study to 
ensure that all responses are associated with 
someone who has been diagnosed as probable, 
possible, or confirmed Alzheimer’s disease. 
Because of the nature of this study it is not 
necessary to survey populations not affected by the 
disease. The sample was collected through the use 
of social media as well as community groups, 
physicians’ offices, and long term care facilities 
(assisted living facilities, memory care units, and 
nursing homes). 
Procedures 
In order to assess the stages of the disease 
quantitatively, only multiple choice questions from 
the CDR were asked. The questions were formatted 
for an online survey. A link to the survey was 
distributed on social media, through the 
Alzheimer’s Association’s TrialMatch website, and 
well as several other locations. Alzheimer’s 
advocacy groups were also notified of the study 
and provided with a link to the survey. 
A link was also given to long term care facilities, 
general physicians and gerontologists, 
psychiatrists, neurologists, and other medical 
practitioners who may be aware of individuals who 
are interested in participating in the study. In order 
to attempt to get representation for both patients 
who are living in a long term care facility and those 
who remain living at home with assistance, in 
home nursing and caregiver services were also 
provided with a link to the online survey. 
The survey included approximately 120 multiple 
choice questions. Questions include demographic 
information as well as 36 questions about the 
patient’s ability to remember and function in his or 
her daily tasks. The participant (the caregiver or 
family member) was asked to remember and report 
on the ability of the individual for first 6 years of 
the individual being diagnosed with probable or 
possible Alzheimer’s disease using 36 questions 
from the CDR. The questions are repeated for each 
of the six years. Participants were notified that it 
was expected that the survey would take 
approximately 45-60 minutes to complete. 
 
RESULTS 
This study will contain a description and overview 
of the data that was collected and analyzed. This 
overview will include a description of the sample, 
the variables, and the scale. The hypotheses will be 
presented as well as an analysis of the data as it 
supports or nullifies the hypothesis. 
Overview of Data Collection 
The study involved responses from 374 
participants. Each of these participants is a friend 
or family member of an individual diagnosed with 
dementia and is acting as an informant on this 
person’s symptoms. Of the 374 people who agreed 
to participate, only 273 participants completed 
enough of the survey to report on at least one year 
of symptoms. Each participant was asked to take a 
122 item questionnaire in order to report on their 
friend or relative’s symptoms over a 6 year period. 
The results of these 273 participants was analyzed 
and then compared in order to determine if there 
was a correlation between the individual’s living 
environment and the speed of progression of the 
disease. 
Participants were recruited through social media, 
email, word of mouth, and The Alzheimer’s 
Association’s Trial Match system. The 
questionnaire was administered online and 
was accessibly by a link provided to each 
participant. Participants were not required to 
complete demographic information, but were given 
requirements that must be met in order to proceed.  
Descriptive Statistics 
Descriptive statistics were calculated in the form of 
standard deviation and mean. The number of 
members in the sample, the standard deviation, and 
the mean of each of the subgroups can be found in 
Table 1. It appears that those who live at home 
independently have a lower mean score than those 
who live in other settings, but this is to be expected 
because many individuals will not move into a 
higher setting of care until it is necessary. The 
speed of progression can be found in the mean 
differences between years, which can also be found 
in Table 1. 
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Participant Numbers, Mean Stage, and Standard Deviations 
 
Year Living Arrangement N Standard 
Deviation 
Mean Mean Difference from 
Previous Year 
Baseline At home independently 168 .73255 1.13185 n/a 
Baseline At home or with 
relatives, but with 
assistance 
94 .68748 1.5699 n/a 
Baseline In an assisted living 
facility 
11 .83029 2.0045 n/a 
1 At home independently 63 .63202 1.2267 .09485 
1 At home or with 
relatives, but with 
assistance 
129 .65215 1.8393 .2694 
1 In an assisted living 
facility 
45 .71537 2.4091 .4046 
2 At home independently 37 .70886 1.4903 .2636 
2 At home or with 
relatives, but with 
assistance 
123 .71491 2.1194 .2801 
2 In an assisted living 
facility 
54 .81893 2.7402 .3311 
3 At home independently 20 .75621 1.5380 .0477 
3 At home or with 
relatives, but with 
assistance 
100 .68429 2.2585 .1391 
3 In an assisted living 
facility 
65 .85475 2.8858 .1456 
4 At home independently 8 .59062 1.0700 -.468 
4 At home or with 
relatives, but with 
assistance 
19 .61145 1.7118 -.5467 
4 In an assisted living 
facility 
72 .74431 2.8555 -.0303 
5 At home independently 2 .9091 2.2143 1.1443 
5 At home or with 
relatives, but with 
assistance 
21 .56512 2.2789 .7439 
5 In an assisted living 
  facility  
13 .38422 2.6923 -0.1632 
 
Hypothesis Testing 
Living Environment Correlates to the Speed of Progression of Alzheimer’s Disease 
The initial hypothesis of this study is that living environment strongly correlates with the progression of 
Alzheimer’s disease. Factors such as regular meals, attention to medication dosage, and outside knowledge of 
symptoms and memory deterioration may assist in the treatment of the disease. Each of the living arrangements 
was compared over a six-year period. In order to determine the speed of progression, the mean differences were 
analyzed among the different living arrangements. 
The results supported the hypothesis, with “living at home independently” showing the slowest speed of 
progression. Table 2 includes the mean differences of each of the living environments over each of the years 
included in the questionnaire. While living at home independently shows the slowest speed of progression, 
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Mean Difference by Living Arrangement 
Year Living Arrangement Mean Difference from Previous Year 
Baseline At home independently n/a 
1 At home independently .09485 
2 At home independently .2636 
3 At home independently .0477 
4 At home independently -.468 
5 At home independently .5014 
Baseline At home or with relatives, but with 
assistance 
n/a 
1 At home or with relatives, but with 
assistance 
.2694 
2 At home or with relatives, but with 
assistance 
.2801 
3 At home or with relatives, but with 
assistance 
.1391 
4 At home or with relatives, but with 
assistance 
-.7385 
5 At home or with relatives, but with 
assistance 
.739 
Baseline In an assisted living facility n/a 
1 In an assisted living facility .4046 
2 In an assisted living facility .3311 
3 In an assisted living facility .1456 
4 In an assisted living facility -.0303 
5 In an assisted living facility -.1632 
 
In early years of the disease, living at 
home independently shows the slowest rate of 
progression. The mean difference between the 
baseline year and year one is 0.09485 in individuals 
living at home independently, while it is 0.2694 in 
those living at home or with relatives, but with 
assistance. The mean difference for this time period 
in those living in an assisted living facility showed 
the greatest rate of progression, with a mean 
difference of 0.4046 from the baseline year to year 
one. 
Between Year 1 and Year 2, the disease 
continues to progress across all living 
environments, however, the mean difference is less 
significant than it is between the baseline year and 
Year 1. The mean difference between Year 1 and 
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Year 2 in individuals living at home independently 
is 0.2636, while the mean difference for those 
living at home or with relatives but with assistance 
is slightly higher at 0.2801. Those living in assisted 
living facilities continue to have a higher rate of 
progression in Year 2, with a mean difference of 
0.3311. 
The mean difference continues to show a slower 
rate of progression in individuals living at home 
independently between Years 2 and 3. The mean 
difference in those living independently in Year 3 
is 0.0477. The mean difference for those living at 
home or with relatives but with assistance during 
the same time period is 0.1391, while the mean 
difference for individuals living in an assisted 
living facility was slightly higher at 0.1456. The 
difference between progressions in the latter two 
living environments at this stage of the disease is 
relatively small. 
Year 4 shows reduced reporting across multiple 
living arrangements, with a decrease from 185 
participants to only 99 participants. It is likely 
because of this that there is a negative mean 
difference between Years 3 and 4. Living at home 
independently shows a mean difference of -0.468. 
Living at home or with relatives but with assistance 
provides a mean difference of - 0.5467. Living in 
an assisted living facility produced a mean 
difference of -0.0303. 
The number of responses for Year 5 was low, with 
only two individuals being reported as living at 
home independently; a decrease of six from the 
previous year, which had eight participants 
reporting that individuals lived at home 
independently in Year 4. Respondents reporting 
that individuals lived at home or with relatives but 
with assistance went up in Year 5. 
Year four showed 19 individuals living at home or 
with relatives, while Year 5 showed 21. The 
greatest numerical decrease in any of the three 
living environments was in the assisted living 
facility living environment. This living 
environment showed a decrease from 72 
respondents in Year 4 to only 13 respondents in 
Year 5. 
Implications of Results 
These results are important for practitioners who 
may advise patients and their families on the most 
appropriate living arrangement for those being 
diagnosed with probable or possible Alzheimer’s 
disease. Those diagnosed with probable or possible 
Alzheimer’s disease may elect to plan ahead for 
where they will live and how they will receive care 
when they are no longer able to make decisions for 
themselves. These results could help practitioners, 
families, and patients to develop these plans 
together. 
Once an individual can no longer make decisions 
about his or her own care, families may be 
confused about how to make the best decision for 
caring for their loved one. It is difficult to find 
research on the benefits of one living environment 
over another. This research was unable to find any 
previous research documenting the progression of 
Alzheimer’s disease compared in different living 
environments. The current research may help 
families to make decisions for their loved one with 
more comfort, ease, and confidence. 
Potential Impact of Results 
The results of this study may assist medical 
professionals when making recommendations to 
those who are being diagnosed with possible or 
probable Alzheimer’s disease. Physicians and 
clinicians often make recommendations about 
living arrangements for those who are diagnosed 
with the disease. Knowing what stage of the 
disease an individual is likely at may assist 
professionals in making a recommendation that 
will best suit the individual. 
Family members of individuals diagnosed with 
probable or possible Alzheimer’s disease may find 
this research useful when making decisions about 
where their loved one will live, especially during 
later stages of the disease when the individual 
diagnosed with dementia may not have the 
cognitive abilities to make sound decisions about 
his or her living arrangements. 
Implications for Practice 
Practitioners can use information developed from 
this study in order to assist individuals with making 
a plan for their living environment while they still 
have the cognitive ability to do so. If this is not 
possible, practitioners can use this research in order 
to further educate the patient’s family about the 
benefits and limitations of each of the living 
environments as it applies to the speed of 
progression of the disease. Assisted living facilities 
can use the current research in order to assist 
families inquiring about assisted living intake for 
individuals with probable or possible Alzheimer’s 
disease. 
Recommendations for Future Research 
 
This study is an initial study using the current data. 
Because of the large data set that was collected 
during the course of this study, future research may 
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use the data in order to study more specific areas of 
the progression of Alzheimer’s disease, its 
symptoms, and various living environments. 
Future Research Using Current Data 
Using the current data, future researchers could 
analyze individual cases in order to determine how 
any change in living environment during the 
progression of the disease may affect cognition and 
the speed of the progression of the disease. Testing 
what happens when an individual changes his or 
her living environment in any way using the 
current data would create approximately 300 
permutations per participant. 
The current data could also be used to determine if 
specific symptoms appear to be more severe in 
some living environments over others. This would 
not test the mean of the symptoms as the current 
study did, it would instead look at one specific 
symptom over a period of several years in order to 
determine if that symptom tends to be more severe 
in one living environment than in others. 
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